CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Conditions:   Hematologic Diseases;   Hematologic Malignancy;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia Interventions:   Device: CliniMACS;   Procedure: Bone Marrow Transplant;   Drug: Hyperfractionated Total Body Irradiation;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Melphalan;   Drug: Fludarabine Sponsor:   Baptist Health South Florida Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials